ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2009;88:246-252. doi:10.1016/j.athoracsur.2009.03.083
© 2009 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Dilip S. Nath
Winfield J. Wells
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nath, D. S.
Right arrow Articles by Wells, W. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nath, D. S.
Right arrow Articles by Wells, W. J.
Related Collections
Right arrow Pleura


Original Articles: General Thoracic

Thoracic Duct Ligation for Persistent Chylothorax After Pediatric Cardiothoracic Surgery

Dilip S. Nath, MD, Jainy Savla, BS, Robinder G. Khemani, MD, Daniel P. Nussbaum, BS, Christina L. Greene, BS, Winfield J. Wells, MD*

Division of Cardiothoracic Surgery, Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California

Accepted for publication March 27, 2009.

* Address correspondence to Dr Wells, Childrens Hospital Los Angeles, Division of Cardiothoracic Surgery, 4650 Sunset Blvd; MS 66, Los Angeles, CA 90027 (Email: wwells{at}chla.usc.edu).

Presented at the Fifty-fifth Annual Meeting of the Southern Thoracic Surgical Association, Austin, TX, Nov 5–8, 2008.

Background: There is considerable literature on incidence and medical management of postsurgical chylothorax in children but little is known about outcomes of thoracic duct ligation (TDL) for patients refractory to medical therapy.

Methods: A retrospective review of patients undergoing TDL after cardiothoracic surgery (1992 through 2007) was done. Data on demographics including cardiac morphology, characteristics of chylous drainage, medical management, and post-TDL course were collected. When available, imaging studies of the upper body venous drainage vessels were examined.

Results: Twenty patients (median age, 0.65 years; range, 0.03 to 11 years; weight, 7.0 kg; range, 2.6 to 30 kg) had a diagnosis of chylothorax made 8.5 days (range, 2 to 118 days) after initial operation. Median duration of pre-TDL medical management was 17.5 days (range, 7 to 69 days). Median drainage for 5 days preceding TDL was 34.5 mL · kg–1 · d–1 (range, 15 to 135 mL · kg–1 · d–1) with maximal output of 65 mL · kg–1 · d–1 (range, 30 to 200 mL · kg–1 · d–1). After TDL, there was a decrease in median drainage to 13 mL · kg–1 · d–1 (range, 4 to 160 mL · kg–1 · d–1; p = 0.003). Chest tubes were removed 8.5 days (range, 4 to 34 days) after TDL. There were 4 deaths (none attributed to TDL), 2 treatment failures (post-TDL chest tube drainage > 2 mL · kg–1 · d–1 > 14 days), and 2 recurrences (after initial chylothorax resolution and hospital discharge). Three patients had documented upper body venous thrombosis. Univariate analysis demonstrated thrombosis of upper body venous vessels (p = 0.02) and prolonged post-TDL chest tube drainage (p = 0.01) were risk factors for death, treatment failure, or chylothorax recurrence.

Conclusions: Thoracic duct ligation leads to a major reduction in chest tube drainage and prompt tube removal in most pediatric patients and should be considered early in refractory postoperative chylothorax. Patients with upper body venous thrombosis associated with chylothorax are at a high risk for failure of TDL and mortality.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.